- Home
- TNON vs SNES Comparison
TNON vs SNES Comparison
Compare TNON & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNON
- SNES
- Stock Information
- Founded
- TNON 2012
- SNES 2004
- Country
- TNON United States
- SNES United States
- Employees
- TNON N/A
- SNES N/A
- Industry
- TNON Medical Specialities
- SNES Agricultural Chemicals
- Sector
- TNON Health Care
- SNES Industrials
- Exchange
- TNON Nasdaq
- SNES Nasdaq
- Market Cap
- TNON 2.2M
- SNES 2.3M
- IPO Year
- TNON 2022
- SNES 2016
- Fundamental
- Price
- TNON $1.85
- SNES $3.16
- Analyst Decision
- TNON Strong Buy
- SNES Strong Buy
- Analyst Count
- TNON 2
- SNES 1
- Target Price
- TNON $16.00
- SNES $10.00
- AVG Volume (30 Days)
- TNON 147.3K
- SNES 311.7K
- Earning Date
- TNON 11-13-2024
- SNES 11-12-2024
- Dividend Yield
- TNON N/A
- SNES N/A
- EPS Growth
- TNON N/A
- SNES N/A
- EPS
- TNON N/A
- SNES N/A
- Revenue
- TNON $3,315,000.00
- SNES $1,651,000.00
- Revenue This Year
- TNON $29.03
- SNES $91.45
- Revenue Next Year
- TNON $100.29
- SNES $101.31
- P/E Ratio
- TNON N/A
- SNES N/A
- Revenue Growth
- TNON 38.30
- SNES 38.16
- 52 Week Low
- TNON $1.82
- SNES $1.90
- 52 Week High
- TNON $17.19
- SNES $21.40
- Technical
- Relative Strength Index (RSI)
- TNON 22.38
- SNES 56.47
- Support Level
- TNON $1.82
- SNES $2.32
- Resistance Level
- TNON $2.30
- SNES $5.00
- Average True Range (ATR)
- TNON 0.13
- SNES 0.52
- MACD
- TNON 0.01
- SNES 0.13
- Stochastic Oscillator
- TNON 5.88
- SNES 35.66
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.